Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology
Go back to Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology| (NASDAQ: DFTX) | Delayed: 38.23 +0.14 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.09 | 52 Week High | $ | |||
| Open | $38.00 | 52 Week Low | $ | |||
| Day High | $39.26 | P/E | N/A | |||
| Day Low | $37.70 | EPS | $ | |||
| Volume | 1,494,409 | |||||
